Biomarker

‘Lab on a Chip’ Could Monitor Exposure to Dangerous Molecules

August 1, 2017

An artists’ rendition of microparticles flowing through a channel and passing through electric fields, where they are detected electronically and barcode-scanned (Photo: Ella Marushchenko and Alexander Tokarev/Ella Maru Studios) [more...]

Lab on a Chip Could Monitor Health, Germs and Pollutants

June 14, 2017

An artists’ rendition of microparticles flowing through a channel and passing through electric fields, where they are detected electronically and barcode-scanned. (Credit: Ella Marushchenko and Alexander Tokarev/Ella Maru Studios) [more...]

IBM Scientists Use Lab-on-a-Chip Nanochannel Technology Designed to “Stretch” DNA to Help Detect Disease

May 29, 2017

IBM (NYSE: IBM) scientists have developed a “lab-on-a-chip” technology that can stretch double-stranded DNA molecules with the potential to efficiently reveal biomarkers that may indicate disease. This technology complements the IBM [more...]

Ultrafast Detection of a Cancer Biomarker Enabled by Innovative Nanobiodevice

April 27, 2017

Researchers have developed a nanobiodevice that can quickly and effectively separate microRNA, short lengths of ribonucleic acid present in bodily fluids, from mixtures of nucleic acids. The nanobiodevice contains a unique array of [more...]

Owlstone Medical Wins $7M for Cancer-detecting Breathalyzer

July 2, 2016

Figure 1 ReCIVA breath sampler, which is used in the lung cancer detection project (Image credit: Owlstone Medical) Owlstone Medical has raised £4.9 million ($7 million) to fund the ongoing clinical trials of its diagnostic breathalyzer [more...]

A Portable Device For Rapid And Highly Sensitive Diagnostics

March 3, 2016

A portable and low-cost diagnostic device has been developed at EPFL. This microfluidic tool, which has been tested with Ebola, requires no bulky equipment. It is thus ideally suited for use in remote regions. When remote regions with [more...]

Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening

January 10, 2016

Jan. 10, 2016– Illumina, Inc. (NASDAQ:ILMN) today announced GRAIL, a new company formed to enable cancer screening from a simple blood test. Powered by Illumina sequencing technology, GRAIL will develop a pan-cancer screening test [more...]